Investor Bpifrance Participations SA
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Bpifrance Participations SA . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-09-05 13D/A VALN / Valneva SE - Depositary Receipt (Common Stock) 14,113,834 21,810,176
2025-05-21 13D/A 11,461,930
2025-05-07 13D/A 7,319,429
2025-04-07 13D/A DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 7,151,863 17,455,376
2025-02-14 13D/A STLA / Stellantis N.V. 203,928,183 393,615,130
2025-01-30 13D/A CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) 6,913,153 10,292,653
2024-09-20 13D/A VALN / Valneva SE - Depositary Receipt (Common Stock) 12,801,207 14,113,834
2024-06-06 13D/A CSTM / Constellium SE 16,393,903 12,593,903
2024-05-21 13D/A CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) 6,913,153 6,913,153
2024-02-14 13G/A STM / STMicroelectronics N.V. - Depositary Receipt (Common Stock) 250,704,754 254,380,285
2024-01-29 13D/A STLA / Stellantis N.V. 202,042,659 203,928,183
2023-11-13 13D/A CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) 6,427,497 6,913,153
2023-08-29 13D/A SQNS / Sequans Communications S.A. - Depositary Receipt (Common Stock) 13,200,072 13,200,072
2023-08-10 13D/A CSTM / Constellium SE 16,393,903
2023-06-30 13D/A VALN / Valneva SE - Depositary Receipt (Common Stock) 11,616,821 12,801,207
2023-02-14 13D/A CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) 3,961,387 6,427,497
2022-12-06 13D/A IPHA / Innate Pharma S.A. - Depositary Receipt (Common Stock) 7,988,369 7,186,628
2022-11-16 13D VALN / Valneva SE - Depositary Receipt (Common Stock) 9,501,441 11,616,821
2022-10-21 13D/A IPHA / Innate Pharma S.A. - Depositary Receipt (Common Stock) 8,952,467 7,988,369
2022-10-20 13D/A VECT / VectivBio Holding AG 2,806,217 2,806,217
2022-06-28 13D/A VECT / VectivBio Holding AG 2,806,217 2,806,217
2022-06-16 13D/A DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 4,668,702 7,151,863
2022-03-17 13D/A SQNS / Sequans Communications S.A. - Depositary Receipt (Common Stock) 13,200,072 13,200,072
2022-02-10 13G VALN / Valneva SE 9,501,441
2022-01-11 13D/A THNPY / Technip Energies N.V. - Depositary Receipt (Common Stock) 12,641,414 16,467,517
2021-11-18 13D/A FTI / TechnipFMC plc 26,151,539 22,119,572
2021-08-09 13D/A SQNS / Sequans Communications S.A. - Depositary Receipt (Common Stock) 13,515,852 13,200,072
2021-05-11 13D/A THNPY / Technip Energies N.V. - Depositary Receipt (Common Stock) 12,641,435 12,641,414
2021-04-23 13D VECT / VectivBio Holding AG 2,806,217
2021-04-23 13D VECT / VectivBio Holding AG 2,806,217
2021-04-09 13D THNPY / Technip Energies N.V. - Depositary Receipt (Common Stock) 12,641,435
2021-04-01 13D/A FTI / TechnipFMC plc 26,167,644 26,151,539
2021-02-19 13D/A FTI / TechnipFMC plc 24,688,691 26,167,644
2021-02-12 13D/A DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 4,604,283 4,668,702
2021-02-12 13D IPHA / Innate Pharma S.A. - Depositary Receipt (Common Stock) 8,952,467
2021-02-12 13G/A ORAN / Orange S.A. - Depositary Receipt (Common Stock) 356,194,433 356,194,433
2021-02-12 13D/A SQNS / Sequans Communications S.A. - Depositary Receipt (Common Stock) 13,515,852
2021-02-12 13D/A CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) 3,896,259 3,961,387
2021-01-25 13D STLA / Stellantis N.V. 202,042,659
2020-08-31 13G/A US8742242071 / Talend S.A. 1,612,895 0
2020-08-04 13D CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) 2,975,500 3,896,259
2020-07-30 13D/A TPST / Tempest Therapeutics, Inc. 1,078,670 590,105
2020-02-12 13G/A US8742242071 / Talend S.A. 2,112,895 1,612,895
2020-02-12 13G/A ORAN / Orange S.A. - Depositary Receipt (Common Stock) 356,194,433 356,194,433
2020-02-11 13G/A STM / STMicroelectronics N.V. - Depositary Receipt (Common Stock) 250,704,754 250,704,754
2019-12-16 13D/A TPST / Tempest Therapeutics, Inc. 1,078,670
2019-10-15 13D/A DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 4,604,283 4,604,283
2019-04-09 13D/A DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 3,268,228 4,604,283
2019-02-12 13G/A STM / STMicroelectronics N.V. - Depositary Receipt (Common Stock) 250,704,754 250,704,754
2018-12-13 13D TPST / Tempest Therapeutics, Inc. 1,078,670
2018-05-07 13D/A DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 2,936,674 3,268,228
2018-04-12 13D DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 1,901,393 2,936,674
2018-02-15 13G/A US8742242071 / Talend S.A. 2,112,895 2,112,895
2018-02-12 13G/A DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 1,743,333 1,901,393
2018-02-12 13G/A ADVM / Adverum Biotechnologies, Inc. 2,640,775 1,345,685
2018-02-08 13D/A CGGYY / Viridien Société anonyme - Depositary Receipt (Common Stock) 2,069,686 536,312
2017-11-08 13D/A CSTM / Constellium SE 13,943,903 16,393,903
2017-09-07 13D/A CSTM / Constellium SE 13,943,903
2017-05-30 13D FTI / TechnipFMC plc 24,688,691
2017-05-30 13D CGGYY / Viridien Société anonyme - Depositary Receipt (Common Stock) 2,069,686
2017-05-11 13G ADVM / Adverum Biotechnologies, Inc. 2,640,775
2017-02-14 13G/A ORAN / Orange S.A. - Depositary Receipt (Common Stock) 356,194,433 356,194,433
2017-02-14 13G/A STM / STMicroelectronics N.V. - Depositary Receipt (Common Stock) 250,704,754
2017-02-14 13G/A STMEF / STMicroelectronics N.V. 250,704,754
2017-02-14 13G DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 1,743,333
2017-02-14 13G US8742242071 / Talend S.A. 2,112,895
2017-02-14 13G/A FNCTF / Orange S.A. 356,194,433 356,194,433
2017-02-14 13G CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) 2,975,500
2016-02-16 13G ORAN / Orange S.A. - Depositary Receipt (Common Stock) 356,194,433
2016-02-16 13G FNCTF / Orange S.A. 356,194,433